³Ô¹ÏÍøÕ¾

Latest biotech News | Page 12

CSL secures US approval for breakthrough one-time haemophilia gene therapy
AusBiotech gets behind campaign to combat ‘silent pandemic’
U.S. Food and Drug Administration approves CSL’s HEMGENIX , first gene therapy for hemophilia B
IND approval from US FDA for theranostic SARBombesin trial in prostate cancer
Zelira Therapeutics announces successful enrolment in new trial Zelira Therapeutics
Phase 2 trial of ChulaCov19 BNA159 mRNA Vaccine to start in Australia
AusBiotech Policy Forum: Biotech leaders head to Parliament
AusBiotech connects sector to celebrate 2022
Telix acquires US radiochemistry business Optimal Tracers
Commercialisation key priority in future MRFF decisions
Brandon Capital Invests in neuroscience company NRG Therapeutics
BiomeBank announces world first regulatory approval for donor derived microbiome drug
QIMR and WEHI take home prizes for best early-stage project
Alterity Therapeutics updates on Multiple System Atrophy study
Telix announces positive topline results of late-stage imaging study
New AusBiotech Board fit for era
CSL R and D Day 2022
Cicada to operate new biotech incubator
CSL Enters Licensing Agreement
Federal Budget mostly ‘vanilla’, with bit of sting
Life sciences industry’s highest achievers celebrated at prestigious Awards ceremony
CSL and Translational Sciences enter Agreement
World-class, locally developed: Australia’s largest annual biotech week kicks off
FDA submission triggers milestone payment for Neuren Pharmaceuticals
AusBiotech’s virtual 2022 AGM open to members
New HQ Earns Sustainability Credentials
ANDHealth CEO recognised with ‘Telstra Brilliant Women in Digital Health Award’
Health Canada approves Telix’s Illuccix for prostate cancer imaging
Ag-Biotech Summit to feature sustainable food
Botanix announces positive BTX 1702 clinical study outcome
Illumina and AstraZenca team up on AI-based research project
Accelerating investment in Queensland’s early-stage companies
2023 CSL Centenary Fellowships awarded
BioNTech chooses Melbourne for its Asia-Pacific mRNA R&D centre
IDT Australia announces new appointments to board of directors
International consultation on medicines and biologicals
Illumina unveils NovaSeq X series to accelerate genomic discoveries
Second fast-track designation for Australian immunotherapy company
Industry responds to proposed regulatory changes for clinical trials of medical devices
NATURE publishes data on DUNP19 receptors role in cancer growth
Move to expand Intellectual Property waiver presents concern
Australian biotechnology incubator Proto Axiom completes initial fundraising
Agilex Biolabs expands capacity with commissioning of new Brisbane facilty
CSL announces seven recipients of ‘Global Research Acceleration Initiative’ awards
New investor guide profiles biotech companies to watch
CSL RAI Awardees Announced
Botanix Pharmaceuticals submits new drug application to FDA
Alterity Therapeutics announces poster presentation from major study